Molina Healthcare Inc. (MOH) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Molina Healthcare Inc.

    NYSE: MOH · Real-Time Price · USD
    202.03
    7.78 (4.01%)
    At close: Oct 03, 2025, 3:59 PM
    198.00
    -1.99%
    After-hours: Oct 03, 2025, 07:38 PM EDT

    Molina Healthcare Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
    Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
    Revenue
    		 43.41B 41.87B 40.65B 39.2B 37.41B 35.85B 34.07B 33.25B 32.63B 32.35B 31.97B 31.16B 30.27B 29.02B 27.77B 25.6B 23.58B 21.4B
    Cost of Revenue
    		 38.66B 37.07B 35.91B 34.53B 32.87B 31.41B 29.74B 28.95B 28.44B 28.32B 28.05B 27.4B 26.68B 25.6B 24.49B 22.57B 20.65B 18.47B
    Gross Profit
    		 4.75B 4.8B 4.74B 4.67B 4.54B 4.45B 4.33B 4.3B 4.19B 4.03B 3.93B 3.76B 3.59B 3.42B 3.28B 3.03B 2.93B 2.92B
    Operating Income
    		 1.65B 1.71B 1.71B 1.64B 1.53B 1.54B 1.57B 1.36B 1.34B 1.26B 1.17B 1.26B 1.15B 1.06B 1.02B 920M 988M 1.14B
    Interest Income
    		 n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
    Pretax Income
    		 1.5B 1.58B 1.59B 1.53B 1.43B 1.44B 1.46B 1.25B 1.23B 1.15B 1.06B 1.12B 1B 914M 875M 790M 861M 1.01B
    Net Income
    		 1.13B 1.18B 1.18B 1.14B 1.06B 1.07B 1.09B 931M 916M 855M 792M 839M 752M 689M 659M 590M 632M 723M
    Selling & General & Admin
    		 2.83B 2.81B 2.74B 2.72B 2.65B 2.58B 2.46B 2.45B 2.4B 2.33B 2.31B 2.26B 2.23B 2.17B 2.07B 1.94B 1.77B 1.64B
    Research & Development
    		 n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
    Other Expenses
    		 270M 276M 286M 299M 352M 322M 299M 488M 450M 446M 442M 238M 211M 195M 192M 172M 164M 148M
    Operating Expenses
    		 3.1B 3.08B 3.03B 3.02B 3.01B 2.9B 2.76B 2.93B 2.85B 2.78B 2.75B 2.5B 2.44B 2.36B 2.26B 2.11B 1.94B 1.78B
    Interest Expense
    		 154M 134M 118M 111M 109M 108M 109M 109M 110M 110M 110M 113M 115M 118M 120M 120M 117M 111M
    Selling & Marketing Expenses
    		 n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
    Cost & Expenses
    		 41.76B 40.15B 38.94B 37.56B 35.87B 34.31B 32.5B 31.89B 31.29B 31.1B 30.8B 29.9B 29.13B 27.96B 26.75B 24.68B 22.59B 20.26B
    Income Tax Expense
    		 369M 404M 410M 388M 363M 365M 373M 322M 312M 291M 271M 282M 253M 225M 216M 200M 229M 290M
    Shares Outstanding (Basic)
    		 54.3M 54.6M 57.4M 57.6M 57.9M 57.9M 58M 57.8M 57.7M 58M 58M 57.6M 57.8M 58M 58M 57.8M 57.7M 57.7M
    Shares Outstanding (Diluted)
    		 54.3M 54.8M 57.7M 57.7M 58.2M 58.3M 58.2M 58.1M 57.9M 58M 58.4M 57.6M 58.4M 58.7M 58.7M 58.5M 58.4M 58.6M
    EPS (Basic)
    		 20.22 20.70 20.43 19.78 18.36 18.52 18.85 16.10 15.85 14.78 13.70 14.51 13.01 11.92 11.42 10.21 10.86 12.38
    EPS (Diluted)
    		 20.19 20.62 20.33 19.69 18.26 18.43 18.80 16.05 15.82 14.73 13.60 14.38 12.85 11.76 11.25 10.07 10.71 12.20
    EBITDA
    		 1.85B 1.9B 1.89B 1.82B 1.71B 1.72B 1.74B 1.54B 1.52B 1.44B 1.35B 1.4B 1.27B 1.17B 1.13B 1.03B 1.09B 1.23B
    EBIT
    		 1.65B 1.71B 1.71B 1.64B 1.53B 1.54B 1.57B 1.36B 1.34B 1.26B 1.17B 1.23B 1.12B 1.03B 995M 910M 978M 1.12B
    Depreciation & Amortization
    		 201M 189M 186M 181M 176M 172M 171M 175M 178M 180M 176M 164M 151M 138M 131M 120M 111M 101M

    Add to Watchlist